(Q38181957)

30 August 2017

title

Stromal cells-are they really useful for GVHD? (English)

1 reference

30 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Behnam Sadeghi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

T Erkers

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

O Ringdén

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

English

0 references

publication date

27 January 2014

1 reference

Bone Marrow Transplantation

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

737-743

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bmt.2013.237

2 June 2020

exact match

0 references

cites work

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

The DSCs-expressed CD82 controls the invasiveness of trophoblast cells via integrinbeta1/MAPK/MAPK3/1 signaling pathway in human first-trimester pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

A cross-talk of decidual stromal cells, trophoblast, and immune cells: a prerequisite for the success of pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

In vivo tracking of 111In-oxine labeled mesenchymal stem cells following infusion in patients with advanced cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stem cells are injured by complement after their contact with serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Murine bone marrow derived stromal progenitor cells fail to prevent or treat acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Publication bias is present in blood and marrow transplantation: an analysis of abstracts at an international meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

White fat progenitor cells reside in the adipose vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

A perivascular origin for mesenchymal stem cells in multiple human organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stromal cells: new directions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Multipotent mesenchymal stromal cells and the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Concise review: hitting the right spot with mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

HLA-G is a crucial immunosuppressive molecule secreted by adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Human mesenchymal stem cells modulate allogeneic immune cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Decidual stromal cells promote regulatory T cells and suppress alloreactivity in a cell contact-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stromal cells inhibit Th17 but not regulatory T-cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Membrane vesicles as conveyors of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Extracellular vesicles: biology and emerging therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Exosomes for drug delivery - a novel application for the mesenchymal stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

How I treat refractory acute GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stem cell as salvage treatment for refractory chronic GVHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesenchymal stromal cells as treatment for chronic GVHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Sarcoma derived from cultured mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Mesoangioblasts, Vessel-Associated Multipotent Stem Cells, Repair the Infarcted Heart by Multiple Cellular Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.237

Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons

21 January 2018

1 reference

12 December 2020

Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease

1 reference

12 December 2020

Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon

1 reference

12 December 2020

HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells

1 reference

12 December 2020

Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation

1 reference

12 December 2020

Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications

1 reference

12 December 2020

Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population

1 reference

12 December 2020

Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients

1 reference

12 December 2020

Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice

1 reference

12 December 2020

Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy

1 reference

12 December 2020

Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation

1 reference

12 December 2020

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

1 reference

12 December 2020

Inherent propensity of amnion-derived mesenchymal stem cells towards endothelial lineage: vascularization from an avascular tissue

1 reference

12 December 2020

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

12 December 2020

Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice

1 reference

12 December 2020

Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study

1 reference

12 December 2020

Human CD8+ regulatory T cells inhibit GVHD and preserve general immunity in humanized mice

1 reference

12 December 2020

Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?

1 reference

12 December 2020

Pooled MSCs for treatment of severe hemorrhage

1 reference

12 December 2020

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

12 December 2020

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

12 December 2020

Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease

1 reference

12 December 2020

Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium

1 reference

12 December 2020

Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantation

1 reference

12 December 2020

Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT

1 reference

12 December 2020

Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kappa B

1 reference

12 December 2020

Natural history of mesenchymal stem cells, from vessel walls to culture vessels.

1 reference

12 December 2020

Xenoreactivity of human clonal mesenchymal stem cells in a major histocompatibility complex-matched allogeneic graft-versus-host disease mouse model

1 reference

12 December 2020

Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells

1 reference

12 December 2020

Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease

1 reference

12 December 2020

Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2013.237

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 June 2020

1005694171

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24464141%20AND%20SRC:MED&resulttype=core&format=json